EP3574309A4 - Magnetic particle-based immunoassay and methods of using the same - Google Patents

Magnetic particle-based immunoassay and methods of using the same Download PDF

Info

Publication number
EP3574309A4
EP3574309A4 EP18744906.1A EP18744906A EP3574309A4 EP 3574309 A4 EP3574309 A4 EP 3574309A4 EP 18744906 A EP18744906 A EP 18744906A EP 3574309 A4 EP3574309 A4 EP 3574309A4
Authority
EP
European Patent Office
Prior art keywords
methods
same
magnetic particle
based immunoassay
immunoassay
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
EP18744906.1A
Other languages
German (de)
French (fr)
Other versions
EP3574309A1 (en
Inventor
Andrew Ward
Arun Richard CHANDRASEKARAN
Daniel Chen
Christopher Blanchard
Padric GARDEN
Bradley DEMARCO
Joshua Forman
Mounir A. KOUSSA
Lisa CALDWELL
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Vital Biosciences Inc
Original Assignee
Vital Biosciences Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Vital Biosciences Inc filed Critical Vital Biosciences Inc
Publication of EP3574309A1 publication Critical patent/EP3574309A1/en
Publication of EP3574309A4 publication Critical patent/EP3574309A4/en
Pending legal-status Critical Current

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/543—Immunoassay; Biospecific binding assay; Materials therefor with an insoluble carrier for immobilising immunochemicals
    • G01N33/54313—Immunoassay; Biospecific binding assay; Materials therefor with an insoluble carrier for immobilising immunochemicals the carrier being characterised by its particulate form
    • G01N33/54326—Magnetic particles
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/543—Immunoassay; Biospecific binding assay; Materials therefor with an insoluble carrier for immobilising immunochemicals
    • G01N33/551—Immunoassay; Biospecific binding assay; Materials therefor with an insoluble carrier for immobilising immunochemicals the carrier being inorganic
    • G01N33/553—Metal or metal coated
EP18744906.1A 2017-01-26 2018-01-26 Magnetic particle-based immunoassay and methods of using the same Pending EP3574309A4 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201762450623P 2017-01-26 2017-01-26
US201762544393P 2017-08-11 2017-08-11
PCT/US2018/015440 WO2018140719A1 (en) 2017-01-26 2018-01-26 Magnetic particle-based immunoassay and methods of using the same

Publications (2)

Publication Number Publication Date
EP3574309A1 EP3574309A1 (en) 2019-12-04
EP3574309A4 true EP3574309A4 (en) 2020-11-11

Family

ID=62978769

Family Applications (1)

Application Number Title Priority Date Filing Date
EP18744906.1A Pending EP3574309A4 (en) 2017-01-26 2018-01-26 Magnetic particle-based immunoassay and methods of using the same

Country Status (4)

Country Link
EP (1) EP3574309A4 (en)
CN (1) CN110462383A (en)
CA (1) CA3051475A1 (en)
WO (1) WO2018140719A1 (en)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2019310583A1 (en) * 2018-07-27 2021-02-04 Veravas, Inc. Methods for depletion and enrichment
CN112415184A (en) * 2019-08-22 2021-02-26 香港科技大学 Single molecule separation system for cell populations and single cells, and methods and uses thereof
CN110618265B (en) * 2019-09-12 2023-04-18 广东省药品检验所（广东省药品质量研究所、广东省口岸药品检验所） Visual detection method of salbutamol
CN111024938B (en) * 2019-11-27 2023-05-26 武汉市农业科学院 Rapid detection method for pathogenic microorganisms
GB202006800D0 (en) * 2020-05-07 2020-06-24 Cambridge Entpr Ltd Carrier system and method
CN116391126A (en) * 2020-08-07 2023-07-04 维塔生物科技公司 Kinetic modulation of magnetic analyte detection
CN116134151A (en) * 2020-08-07 2023-05-16 维塔生物科技公司 Multiplex analyte detection
GB202019024D0 (en) * 2020-12-02 2021-01-13 Paraytec Ltd Diagnostic testing
CN112710858A (en) * 2020-12-15 2021-04-27 深圳天辰医疗科技有限公司 Kit and preparation method and application thereof
CN112526121B (en) * 2020-12-18 2022-11-18 深圳普门科技股份有限公司 Serum amyloid A detection kit and detection system thereof
CN112748096B (en) * 2020-12-29 2022-03-18 山西大学 Room-temperature phosphorescence detection method for sulfadimethoxine and application thereof
CN112763484B (en) * 2021-01-27 2022-05-03 南京医科大学 Method for detecting glutathione and/or hydrogen peroxide based on colorimetric biosensor
CN113373156A (en) * 2021-06-30 2021-09-10 四川携光生物技术有限公司 NMDAR recombinant protein related to autoimmune encephalitis, and coding sequence, preparation method and application thereof
CN114152741B (en) * 2021-11-18 2022-08-19 上海北昂医药科技股份有限公司 dELISA sample for improving effective microbead proportion and preparation and detection method thereof
CN113960313B (en) * 2021-12-22 2022-04-12 上海思路迪医学检验所有限公司 Exosome ALK fusion protein magnetic immunochemiluminescence detection kit
CN114706023A (en) * 2022-06-06 2022-07-05 中国科学技术大学 Magnetic detection method for biomolecular interaction

Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20110065209A1 (en) * 2009-08-31 2011-03-17 Mbio Diagnostics, Inc. Integrated Sample Preparation and Analyte Detection
WO2013189502A1 (en) * 2012-06-22 2013-12-27 Scandinavian Micro Biodevices Aps A method and a system for quantitative or qualitative determination of a target component
US20140170767A1 (en) * 2012-11-30 2014-06-19 Korea Institute Of Science And Technology Method for diagnosing biomarkers and biomarker diagnosis kit

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2000024941A1 (en) * 1998-10-27 2000-05-04 Clinical Micro Sensors, Inc. Detection of target analytes using particles and electrodes
US6607922B2 (en) * 2000-03-17 2003-08-19 Quantum Design, Inc. Immunochromatographic assay method and apparatus
CN100420947C (en) * 2005-05-30 2008-09-24 孙东旭 Method for quantitative determination of specific analyte with single trapping agent and reagent kit therefor
US10488408B2 (en) * 2006-05-09 2019-11-26 Koninklijke Philips N.V. Detection of target molecules in a sample by using a magnetic field
US8873038B2 (en) * 2010-10-27 2014-10-28 The Board Of Trustees Of The University Of Illinois Tailored raman spectrocopic probes for ultrasensitive and highly multiplexed assays
EP2629095A1 (en) * 2012-02-17 2013-08-21 Biosure R & T Cell Co. Detection of mycobacterial protein targets using quantum dots (QDs) and immunomagnetic seperation
US9599610B2 (en) * 2012-12-19 2017-03-21 Dnae Group Holdings Limited Target capture system
US9891227B2 (en) * 2014-05-02 2018-02-13 Academia Sinica Ultrasensitive detection of a biological target by aptamer-conjugated gold nanoparticles

Patent Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20110065209A1 (en) * 2009-08-31 2011-03-17 Mbio Diagnostics, Inc. Integrated Sample Preparation and Analyte Detection
WO2013189502A1 (en) * 2012-06-22 2013-12-27 Scandinavian Micro Biodevices Aps A method and a system for quantitative or qualitative determination of a target component
US20140170767A1 (en) * 2012-11-30 2014-06-19 Korea Institute Of Science And Technology Method for diagnosing biomarkers and biomarker diagnosis kit

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
See also references of WO2018140719A1 *

Also Published As

Publication number Publication date
WO2018140719A1 (en) 2018-08-02
CA3051475A1 (en) 2018-08-02
EP3574309A1 (en) 2019-12-04
CN110462383A (en) 2019-11-15

Similar Documents

Publication Publication Date Title
EP3574309A4 (en) Magnetic particle-based immunoassay and methods of using the same
EP3723803A4 (en) Anti-trem2 antibodies and related methods
EP3515478A4 (en) Antibodies for siglec-15 and methods of use thereof
EP3572427A4 (en) Bcma-targeting antibody and use thereof
EP3383430A4 (en) Antibodies and methods of use thereof
EP3504243A4 (en) Anti-tim-3 antibodies and use thereof
EP3454900A4 (en) Cd47 antibodies and methods of use thereof
EP3383431A4 (en) Anti-gitr antibodies and methods of use thereof
EP3280441A4 (en) Anti-sortilin antibodies and methods of use thereof
EP3634430A4 (en) Multibiotic agents and methods of using the same
IL276515A (en) Pd-l1-specific antibodies and methods of using the same
EP3684821A4 (en) Anti-hla-a2 antibodies and methods of using the same
EP3852805A4 (en) Anti-lilrb2 antibodies and methods of use thereof
EP3436476A4 (en) Anti-ryk antibodies and methods of using the same
EP3383917A4 (en) Novel anti-claudin antibodies and methods of use
EP3675906A4 (en) Anti-tm4sf1 antibodies and methods of using same
EP3559042A4 (en) Anti-lilrb3 antibodies and methods of use thereof
EP3625253A4 (en) Activatable antibodies and methods of use thereof
EP3525583A4 (en) Anti-c1s antibodies and methods of use thereof
EP3728323A4 (en) Anti-frizzled antibodies and methods of use
EP3710589A4 (en) Anti-c1s antibodies and methods of use
EP3684819A4 (en) Anti-ykl40 antibodies and methods of use
EP3567054A4 (en) Anti-alpha-syn antibody and use thereof
AU2017271189A1 (en) Cytosol-penetrating antibody and use thereof
EP3579860A4 (en) TRAILshort ANTIBODY AND METHODS OF USE

Legal Events

Date Code Title Description
STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: THE INTERNATIONAL PUBLICATION HAS BEEN MADE

PUAI Public reference made under article 153(3) epc to a published international application that has entered the european phase

Free format text: ORIGINAL CODE: 0009012

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: REQUEST FOR EXAMINATION WAS MADE

17P Request for examination filed

Effective date: 20190730

AK Designated contracting states

Kind code of ref document: A1

Designated state(s): AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MK MT NL NO PL PT RO RS SE SI SK SM TR

AX Request for extension of the european patent

Extension state: BA ME

DAV Request for validation of the european patent (deleted)
DAX Request for extension of the european patent (deleted)
REG Reference to a national code

Ref country code: DE

Ref legal event code: R079

Free format text: PREVIOUS MAIN CLASS: G01N0021760000

Ipc: G01N0033553000

A4 Supplementary search report drawn up and despatched

Effective date: 20201012

RIC1 Information provided on ipc code assigned before grant

Ipc: G01N 33/553 20060101AFI20201006BHEP

Ipc: G01N 33/543 20060101ALI20201006BHEP

P01 Opt-out of the competence of the unified patent court (upc) registered

Effective date: 20230515

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: EXAMINATION IS IN PROGRESS

17Q First examination report despatched

Effective date: 20230714